Saturday, June 13, 2026
🇺🇸 FDA

pharma · Nasopharyngeal Carcinoma · Hepatocellular Carcinoma

Chinese Academy of

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Chinese Academy of clinical programs — 1328 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
China, TAIZHOU, CN HQ
170 Employees
NMPA registrant Type
Company details
Status
Public
HQ
China, TAIZHOU, CN
Employees
170
Programs
1328
Drugs
711
Patents
335
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Chinese Academy of projects

1,328 ClinicalTrials.gov programs sponsored by Chinese Academy of.

Chinese Academy of has 1,328 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,328 programs

Clinical programs

Page 26 of 28

  1. Pregabalin capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Fibromyalgia

    small molecule completed

    1 trial

  2. Prepackaged Low-residue diet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colon Polyp

    other completed

    1 trial

  3. Probiotics daily

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    SARS-CoV-2

    other completed

    1 trial

  4. Propofol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastroscopy

    small molecule completed

    1 trial

  5. Propranolol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Retinopathy of Prematurity

    small molecule active

    1 trial

  6. Propranolol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cirrhoses

    small molecule active

    1 trial

  7. Propranolol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Portal Hypertension

    small molecule active

    1 trial

  8. Pulsed dye laser (PDL)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Port Wine Stain

    other completed

    1 trial

  9. QFR

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    other active

    1 trial

  10. Raman spectrum

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    other active

    1 trial

  11. Recombinant COVID-19 Vaccine (Sf9 Cell)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    mab completed

    1 trial

  12. Reduction CTVp1

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    other active

    1 trial

  13. Ringer's solution acetate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cholecystolithiasis and Thyroid Nodule

    small molecule completed

    1 trial

  14. Rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral T-Cell Lymphoma, Not Otherwise Specified

    small molecule active

    1 trial

  15. Rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Thrombocytopenic Purpura

    small molecule completed

    1 trial

  16. Rivaroxaban

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ventricular Mural Thrombosis

    small molecule completed

    1 trial

  17. Rivaroxaban

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cirrhosis

    small molecule active

    1 trial

  18. Ropivacaine Hydrochloride 10 MG/ML [Naropin]

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    small molecule active

    1 trial

  19. S-ketamine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anesthesia

    small molecule active

    1 trial

  20. SCOUT-Assisted Review Workflow

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease (CHD)

    other active

    1 trial

  21. SGLT2 inhibitor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Kidney Transplantation

    small molecule completed

    1 trial

  22. SWKCART24031101

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Diseases

    small molecule active

    1 trial

  23. Salvianolic Acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stroke

    small molecule terminated

    1 trial

  24. Sarcosine Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Parkinson's Disease With Dementia

    other completed

    1 trial

  25. Sertraline plus placebo of JWXYJN

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Depressive Disorder

    small molecule active

    1 trial

  26. Sheng-Yu-Tang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Leukemia

    other completed

    1 trial

  27. Simvastatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hyperlipidemias

    small molecule active

    1 trial

  28. Single dose of 2L PEG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Health Behavior

    small molecule completed

    1 trial

  29. Siwu Tang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Brain Hypoperfusion Syndrome

    small molecule active

    1 trial

  30. Solifenacin Succinate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Overactive Bladder

    small molecule active

    1 trial

  31. Spleen Invigorating and Weight Reducing Decoction

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Traditional Chinese Medicine Treatment

    small molecule active

    1 trial

  32. Split dose of 4L PEG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Health Behavior

    small molecule active

    1 trial

  33. Stereotactic body radiotherapy (SBRT)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HSCT

    other active

    1 trial

  34. Study Product A (High-dose 2X)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hyperuricemia

    other active

    1 trial

  35. Subconjunctival dexamethasone and general anesthesia

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cataract

    small molecule active

    1 trial

  36. Surgery combined with Target-reduction intensity-modulated radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    other active

    1 trial

  37. Surgery-radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    other active

    1 trial

  38. TNK plus standard medical treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke

    small molecule active

    1 trial

  39. TPO-RA

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Immune Thrombocytopenic Purpura

    small molecule active

    1 trial

  40. Tacrolimus+Mycophenolate mofetil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    small molecule completed

    1 trial

  41. Tadalafil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Arterial Hypertension (PAH)

    small molecule active

    1 trial

  42. Tafolecimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Coronary Syndrome

    small molecule active

    1 trial

  43. Tamsulosin Hydrochloride

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Benign Prostatic Hyperplasia

    small molecule active

    1 trial

  44. Telmisartan

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    small molecule completed

    1 trial

  45. Terlipressin treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Shock

    small molecule completed

    1 trial

  46. Ticagrelor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Brain Disease

    small molecule active

    1 trial

  47. Tislelizumab combined with Lenvatinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Initially Unresectable Hepatocellular Carcinoma

    small molecule active

    1 trial

  48. Topical compound tripterygium

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Active Rheumatoid Arthritis

    small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Chinese Academy of have?

1,328 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.